Objectives: The aim of this study was to characterize a putative novel macrolide efflux gene located in the vicinity of sul3 in porcine Escherichia coli.
Introduction
Sulphonamides were the first group of systemic antimicrobials introduced into medicine and have been used extensively since then. 1 For decades, only two acquired sulphonamide resistance genes were known, sul1 and sul2, both of which encode plasmidborne sulphonamide-resistant dihydropteroate synthase enzymes. 1 However, a third sulphonamide resistance gene, sul3, was described in 2003, isolated from porcine Escherichia coli. 2 Emergence of sul3 implies that there is still positive selection pressure for sulphonamide resistance, despite the use of the drug being limited in many countries. This may due to the relatively high use of trimethoprim/sulfamethoxazole in veterinary medicine, along with other antimicrobials such as tetracyclines and macrolides.
The mef(A) gene encodes a macrolide-efflux pump that mediates resistance to 14-and 15-membered macrolides in Grampositive bacteria. 3 It belongs to the major facilitator superfamily (MFS) of efflux pumps and is encoded on transposable elements such as Tn1207.1. 3 Although enteric bacteria such as E. coli are often non-susceptible to macrolide antibiotics due to the presence of chromosomal efflux pumps, they can nevertheless acquire genes such as mef(A) or erm(B) that increase their resistance levels further. 4 While investigating the prevalence and genetic context of sul3 among porcine E. coli from Great Britain, a novel gene coding for a putative macrolide efflux protein was identified upstream of sul3 in three isolates, the characterization of which is described here.
Materials and methods

Bacterial isolates and MIC determination
Sixty-two sulphonamide-resistant E. coli obtained from a study investigating the prevalence of antimicrobial resistance genes among isolates from farm animals were studied. 5 Susceptibility to ampicillin, azithromycin, chloramphenicol, clindamycin, erythromycin, streptomycin, sulfamethoxazole, tetracycline and trimethoprim was determined by Etest (AB Biodisk, Solna, Sweden), and susceptibility to ciprofloxacin, ceftazidime, gentamicin, kanamycin and nalidixic acid was determined by disc diffusion. All susceptibility tests were carried out and interpreted according to BSAC guidelines. 6 PCR and DNA sequencing PCR amplification was used to detect the presence of sul3 and class 1 integron integrase, using previously published primers and conditions 2, 5 with Hi-Fidelity PCR Master Mix (Thermo, Epsom, UK). The putative macrolide efflux gene was sequenced during an investigation of the genetic context of sul3, which was determined using a two-step random PCR technique 7 in which primers targeted at the extremities of sul3 were used in conjunction with random primers to obtain the adjacent unknown sequence. Amplification products were separated by agarose gel electrophoresis and visualized under UV light. They were purified with the Qiaquick Gel Extraction Kit (Qiagen, Crawley, UK), according to the manufacturer's instructions, and sent for sequencing at the Advanced Biotechnology Centre, Imperial College, London, UK. Gaps in sequence were filled by primer walking. Sequence analysis was carried out using the Lasergene DNASTAR software package. Similarity to known sequences was searched for using BLAST. The GenBank accession numbers of the sequences described here are FJ196384 (P126. 10 
Random amplification of polymorphic DNA (RAPD) PCR
RAPD PCR was carried out to determine relatedness among isolates, as described previously. 8 
Plasmid analysis
Transfer of antibiotic resistance plasmids by conjugation was attempted using the agar mating method, 9 using E. coli K12 JM109 as the recipient. Plasmid DNA was extracted from E. coli isolates grown overnight in Luria -Bertani (LB) broth containing 500 mg/L sulfamethoxazole, using a Qiaquick Miniprep Kit (Qiagen), according to the manufacturer's instructions. Plasmid DNA was transformed by electroporation into electrocompetent E. coli K12 JM109 cells. Transconjugants and transformants were selected on Iso-Sensitest agar (Oxoid, Basingstoke, UK), containing 500 mg/L sulfamethoxazole and 50 mg/L nalidixic acid. Plasmids present in the transconjugants and transformants were visualized on agarose gels. Plasmid size was estimated following restriction enzyme digestion with BamHI and HindIII (Promega, Southampton, UK).
Cloning
To obtain the DNA sequence of the antibiotic resistance-encoding region of pP286, plasmid DNA was digested with BamHI and HindIII or EcoRI and PstI (Promega). Digested DNA was ligated into pK18 vector and transformed into E. coli K12 JM109. Transformants were selected on LB agar containing kanamycin (30 mg/L), X-gal (40 mg/L) and IPTG (1 mM). Plasmid DNA was extracted from white colonies and the DNA sequence of the inserts obtained, as described earlier. To clone the putative macrolide efflux gene on pP286, DNA was digested with PstI and SacI, ligated into pK18 and transformed by electroporation into E. coli Inhibitor studies of cloned putative macrolide efflux gene
The susceptibility of E. coli K12 JM109 with and without the pK18mef clone to erythromycin was measured by Etest in the presence and absence of the efflux inhibitors carbonyl cyanide m-chlorophenylhydrazone (CCCP; 1 mg/L), omeprazole (100 mg/L), Phe-Arg b-naphthylamide dihydrochloride (PAbND; 80 mg/L) and reserpine (25 mg/L). All inhibitor compounds were purchased from Sigma (Poole, UK).
Results and discussion
Characteristics of isolates and plasmids
Sixty-two sulphonamide-resistant E. coli, isolated at slaughter from healthy farm animals in Great Britain in 1999, 5 were screened for the presence of sul3 by PCR. The antimicrobial susceptibility profile of the isolates and carriage of other resistance genes had previously been determined. 5 Twelve isolates carried sul3, of which five were chosen for further characterization (Table 1 ). All five were isolated from pigs and originated from different abattoirs. They were demonstrated to be distinct by RAPD-PCR. To the best of our knowledge, these isolates are among the earliest described sul3-encoding isolates, suggesting that the sul3 gene emerged in the E. coli population during the 1990s or before.
The plasmid content of the five isolates was investigated. None of the sul3-coding plasmids could be conjugated, although they could be mobilized by larger plasmids from two of the isolates, P126.11.99.C1 and P328. 10 DNA sequences in the vicinity of the sul3 gene 
